newsfilter
← Latest News
ClinicalTrials.gov·

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis - NCT05287126

Proportion of Participants Achieving Clinical Remission as Assessed by Modified Mayo Score (MMS) at Week 52, Plasma Concentration of Etrasimod at 4 Hours Post-dose (C4h), Plasma Steady State Trough Concentration (Ctrough,ss) of Etrasimod, (and 15 more...)